Glucose Transporter Type 1 Deficiency Syndrome: A Single-Center Case Series

Glucose transporter type 1 deficiency syndrome is a neurometabolic encephalopathy characterized by movement disorders, intractable seizures, and acquired microcephaly. Two girls and a boy between the ages of 3 and 15 years were included in this study. The main clinical manifestations were seizure, a...

Full description

Bibliographic Details
Main Authors: Miraç Yıldırım, Ömür Babayiğit, Fatma Ilgaz, Dilek Yalnızoğlu, Meral Topçu
Format: Article
Language:English
Published: Galenos Yayinevi 2021-09-01
Series:Türk Nöroloji Dergisi
Subjects:
Online Access:https://tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-12979&look4=
_version_ 1797906308631887872
author Miraç Yıldırım
Ömür Babayiğit
Fatma Ilgaz
Dilek Yalnızoğlu
Meral Topçu
author_facet Miraç Yıldırım
Ömür Babayiğit
Fatma Ilgaz
Dilek Yalnızoğlu
Meral Topçu
author_sort Miraç Yıldırım
collection DOAJ
description Glucose transporter type 1 deficiency syndrome is a neurometabolic encephalopathy characterized by movement disorders, intractable seizures, and acquired microcephaly. Two girls and a boy between the ages of 3 and 15 years were included in this study. The main clinical manifestations were seizure, ataxia, global developmental delay, and acquired microcephaly. The most common electroencephalographic finding was interictal focal or generalized epileptiform discharges. The cerebrospinal fluid to blood glucose ratio was determined to be low (0.35 and 0.40). Two cases had heterozygous de novo mutations and one had microdeletion of SLC2A1. All cases were treated with a ketogenic diet (KD) and were seizure-free in the sixth month of the diet. KD also improved ataxic gait, language skills, and behavioral disturbances. Inconsistency was demonstrated between electroencephalography findings and seizure semiologies detected in patients with GLUT1DS, and KD was found to be most effective for seizures and less effective for ataxia, language skills, and behavioral disturbances.
first_indexed 2024-04-10T10:18:47Z
format Article
id doaj.art-50712f2788414a648ab6c8ea2e7c25f4
institution Directory Open Access Journal
issn 1309-2545
language English
last_indexed 2024-04-10T10:18:47Z
publishDate 2021-09-01
publisher Galenos Yayinevi
record_format Article
series Türk Nöroloji Dergisi
spelling doaj.art-50712f2788414a648ab6c8ea2e7c25f42023-02-15T16:21:43ZengGalenos YayineviTürk Nöroloji Dergisi1309-25452021-09-0127334334610.4274/tnd.2021.12979Glucose Transporter Type 1 Deficiency Syndrome: A Single-Center Case SeriesMiraç Yıldırım0https://orcid.org/0000-0002-0215-1043Ömür Babayiğit1https://orcid.org/0000-0001-6447-035XFatma Ilgaz2https://orcid.org/0000-0002-6518-0255Dilek Yalnızoğlu3https://orcid.org/0000-0001-9294-4305Meral Topçu4https://orcid.org/0000-0003-0484-8888Ankara University Faculty of Medicine, Department of Pediatric Neurology, Ankara, TurkeyHacettepe University Faculty of Medicine, Department of Pediatric Neurology, Ankara, TurkeyHacettepe University Faculty of Health Sciences, Department of Nutrition and Dietetics, Ankara, TurkeyHacettepe University Faculty of Medicine, Department of Pediatric Neurology, Ankara, TurkeyHacettepe University Faculty of Medicine, Department of Pediatric Neurology, Ankara, TurkeyGlucose transporter type 1 deficiency syndrome is a neurometabolic encephalopathy characterized by movement disorders, intractable seizures, and acquired microcephaly. Two girls and a boy between the ages of 3 and 15 years were included in this study. The main clinical manifestations were seizure, ataxia, global developmental delay, and acquired microcephaly. The most common electroencephalographic finding was interictal focal or generalized epileptiform discharges. The cerebrospinal fluid to blood glucose ratio was determined to be low (0.35 and 0.40). Two cases had heterozygous de novo mutations and one had microdeletion of SLC2A1. All cases were treated with a ketogenic diet (KD) and were seizure-free in the sixth month of the diet. KD also improved ataxic gait, language skills, and behavioral disturbances. Inconsistency was demonstrated between electroencephalography findings and seizure semiologies detected in patients with GLUT1DS, and KD was found to be most effective for seizures and less effective for ataxia, language skills, and behavioral disturbances.https://tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-12979&look4=glucose transporter type 1 deficiency syndromeataxiaslc2a1ketogenic diet
spellingShingle Miraç Yıldırım
Ömür Babayiğit
Fatma Ilgaz
Dilek Yalnızoğlu
Meral Topçu
Glucose Transporter Type 1 Deficiency Syndrome: A Single-Center Case Series
Türk Nöroloji Dergisi
glucose transporter type 1 deficiency syndrome
ataxia
slc2a1
ketogenic diet
title Glucose Transporter Type 1 Deficiency Syndrome: A Single-Center Case Series
title_full Glucose Transporter Type 1 Deficiency Syndrome: A Single-Center Case Series
title_fullStr Glucose Transporter Type 1 Deficiency Syndrome: A Single-Center Case Series
title_full_unstemmed Glucose Transporter Type 1 Deficiency Syndrome: A Single-Center Case Series
title_short Glucose Transporter Type 1 Deficiency Syndrome: A Single-Center Case Series
title_sort glucose transporter type 1 deficiency syndrome a single center case series
topic glucose transporter type 1 deficiency syndrome
ataxia
slc2a1
ketogenic diet
url https://tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-12979&look4=
work_keys_str_mv AT miracyıldırım glucosetransportertype1deficiencysyndromeasinglecentercaseseries
AT omurbabayigit glucosetransportertype1deficiencysyndromeasinglecentercaseseries
AT fatmailgaz glucosetransportertype1deficiencysyndromeasinglecentercaseseries
AT dilekyalnızoglu glucosetransportertype1deficiencysyndromeasinglecentercaseseries
AT meraltopcu glucosetransportertype1deficiencysyndromeasinglecentercaseseries